Esc Congress 2023 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Esc congress 2023. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Esc Congress 2023 Today - Breaking & Trending Today

CASTLE-HTx: Catheter Ablation Improves Outcomes in Heart Failure with AFib

The CASTLE-HTx trial provides insight into the effects of catheter ablation in patients with AFib and end-stage heart failure, with potentially practice-changing implications. ....

Christian Sohns , Diabetes Center North Rhine , European Society Of Cardiology , European Society , Diabetes Center North , Castle Htx , Ablation In Heart Failure , Heart Failure , Atrial Fibrillation , Esc Congress 2023 ,

Bempedoic Acid Proves Cardiovascular Benefit Across Glycemic Spectrum in New Analysis

A prespecified analysis of the CLEAR Outcomes trial assessing outcomes according to glycemic status suggests bempedoic acid provided similar relative benefits across the glycemic spectrum, but the greatest absolute benefits were observed in patients with diabetes. ....

City Of , United Kingdom , Noord Holland , Kausik Ray , Campbellp Bempedoic , Sheldon Koenig , American College Of Cardiology , Esperion Therapeutics Inc , Institute Kausik Ray , European Society Of Cardiology , Imperial College London , European Society Of Cardiology Congress , European Society , Imperial College , American College , New Onset Diabetes , Glycaemic Status , Bempedoic Acid , Prespecified Analyses , Cardiology Congress , Statin Intolerance , Esc Congress 2023 , Bempedoic Acid Nexlizet ,

Dr Milton Packer Shares "Extraordinary" Results From the EMPEROR Trial

The EMPEROR trial showed that within 30 days of stopping empagliflozin, patients had a 70% higher risk of heart failure events, explained Milton Packer, MD, Baylor University Medical Center. ....

Baylor University , United States , Milton Packer , European Society Of Cardiology , Baylor University Medical Center , European Society , Esc Congress 2023 , Emperor Trial , Sglt2 Inhibitor ,

Physician Bias Contributes to Already-Existing Health Inequities in Cardiology, Says Dr Shrilla Banerjee

There seems to be an institutional ignorance toward social determinants of health and actually making changes to improve outcomes for patients of color, said Shrilla Banerjee, MD, FRCP, consultant cardiologist, Surrey and Sussex Healthcare NHS Trust. ....

United Kingdom , East Sussex , United States , Shrilla Banerjee , European Society Of Cardiology , Sussex Healthcare , European Society , Esc Congress 2023 , Social Determinants Of Health , Implicit Bias ,

FRAIL-AF: Switching to NOACs in Older, Frail Patients Linked to Increased Bleeding Risk

Results of the FRAIL-AF trial at ESC Congress 2023 provide clinicians with further clarity into the effects of switching from vitamin K antagonists to NOACs in older patients with frailty and atrial fibrillation. ....

Linda Joosten , Health Sciences , University Medical Center Utrecht Linda Joosten , Julius Center , European Society Of Cardiology , University Medical Center Utrecht , Primary Care , University Medical Center , European Society , Groningen Frailty Indicator , Data Safety , Monitoring Board , Esc Congress , Esc Congress 2023 , Frail Af , Vitamink Antagonists , Atrial Fibrillation ,